Page 8 - Astrazeneca

EU not to renew AstraZeneca, J&J Covid-19 vaccine contracts on expiry

A spokesman for the EU Commission said it was keeping all options open to be prepared for the next stages of the pandemic, for 2022 and beyond

In world first, Denmark ditches AstraZeneca's coronavirus vaccine

Many countries in Europe and elsewhere have resumed administering the shot, with some restricting its use to certain age groups, mostly those aged above 50 or above 60.

Canada will change AstraZeneca license terms if issues emerge: Patty Hajdu

Canadian health regulators will not hesitate to change the terms of the AstraZeneca coronavirus vaccine license if additional safety issues emerge, Health Minister Patty Hajdu said

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

India becomes 60th nation to approve Sputnik V Covid-19 vaccine: Russia

Sputnik V, developed by Moscow's Gamaleya Institute, has proved 91.6% effective against Covid-19

India's Covid crisis stems from arrogance, hyper-nationalism, incompetence

Regulatory uncertainty, bullying, and contempt for legitimate profit-making is familiar to every entrepreneur in India.

Australia drops vaccine rollout target amid concerns about AstraZeneca shot

Australia last week said it is guiding against giving the AstraZeneca vaccine to people under the age of 50.

Unnecessary panic: Astra vaccine unmasks the great East-West divide

'Let's not become part of that war between the different firms, because it's already visible'

Covid-19 vaccination sites drop to half in India amid shortage of doses

Number of locations down from 120,000 to 60,000 from April 3 to 7

EU reviews J&J Covid-19 vaccine for blood clots, expands AstraZeneca probe

Four serious cases of rare blood clots with low platelets have been reported after inoculation with J&J's vaccine from its Janssen unit

Is it safe? Global concern over the use of AstraZeneca vaccine explained

In India, Serum Institute of India is manufacturing AstraZeneca's vaccine under the brand Covishield

'Equitable distribution': Covax says Serum bound to supply virus vaccines

India could resume vaccine exports by June, the firm's chief executive, Adar Poonawalla, told media this week

Serum Institute refunds South Africa for undelivered Covid-19 vaccines

A million doses from the Indian company already delivered have been sold on to other countries in the African Union.

Oxford-AstraZeneca blood clot risk similar to long-haul flight: UK minister

The level of risk from an extremely rare form of blood clot being investigated as possible link with the Oxford/AstraZeneca vaccine is at the same as taking a long-haul flight, UK health minister said

Australia halts AstraZeneca Covid-19 vaccine for most people under 50

Australia on Thursday become the latest country to restrict use of the AstraZeneca vaccine by recommending that it not be given to people under age 50

AstraZeneca blood clot worries complicate bid to vaccinate the world

Reviews by UK and EU regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on

European stocks scale all-time highs with miners in the lead

The pan-European STOXX 600 rose 0.5% by 0720 GMT,

Italy, Britain still recommend AstraZeneca vaccine but suggest age limits

British say benefits outweigh risks for vast majority. Most cases of blood clots found in women under 60, EMA says

Possible link between AstraZeneca's Covid vaccine and clots: EU regulator

Oxford pauses trial among children; UK offers alternative to under-30s